These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21802490)

  • 1. Prostate cancer stem cells: are they androgen-responsive?
    Oldridge EE; Pellacani D; Collins AT; Maitland NJ
    Mol Cell Endocrinol; 2012 Sep; 360(1-2):14-24. PubMed ID: 21802490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications.
    Deng Q; Tang DG
    Endocr Relat Cancer; 2015 Dec; 22(6):T209-20. PubMed ID: 26285606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
    Bonkhoff H; Remberger K
    Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
    Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G
    Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen signaling is essential for development of prostate cancer initiated from prostatic basal cells.
    He Y; Hooker E; Yu EJ; Cunha GR; Liao L; Xu J; Earl A; Wu H; Gonzalgo ML; Sun Z
    Oncogene; 2019 Mar; 38(13):2337-2350. PubMed ID: 30510232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer stem cells: do they have a basal or luminal phenotype?
    Maitland NJ; Frame FM; Polson ES; Lewis JL; Collins AT
    Horm Cancer; 2011 Feb; 2(1):47-61. PubMed ID: 21761340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.
    Montgomery RB; Mostaghel EA; Vessella R; Hess DL; Kalhorn TF; Higano CS; True LD; Nelson PS
    Cancer Res; 2008 Jun; 68(11):4447-54. PubMed ID: 18519708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model.
    Sato N; Gleave ME; Bruchovsky N; Rennie PS; Goldenberg SL; Lange PH; Sullivan LD
    J Steroid Biochem Mol Biol; 1996 May; 58(2):139-46. PubMed ID: 8809195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen action and metabolism in prostate cancer.
    Green SM; Mostaghel EA; Nelson PS
    Mol Cell Endocrinol; 2012 Sep; 360(1-2):3-13. PubMed ID: 22453214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of steroid hormones in prostate cancer.
    Wilding G
    Cancer Surv; 1992; 14():113-30. PubMed ID: 1423327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population.
    Heer R; Robson CN; Shenton BK; Leung HY
    J Cell Physiol; 2007 Sep; 212(3):572-8. PubMed ID: 17541959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into prostate cancer stem cells.
    Chen X; Rycaj K; Liu X; Tang DG
    Cell Cycle; 2013 Feb; 12(4):579-86. PubMed ID: 23370446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells.
    Berger R; Febbo PG; Majumder PK; Zhao JJ; Mukherjee S; Signoretti S; Campbell KT; Sellers WR; Roberts TM; Loda M; Golub TR; Hahn WC
    Cancer Res; 2004 Dec; 64(24):8867-75. PubMed ID: 15604246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor involvement in the progression of prostate cancer.
    Suzuki H; Ueda T; Ichikawa T; Ito H
    Endocr Relat Cancer; 2003 Jun; 10(2):209-16. PubMed ID: 12790784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen regulation of micro-RNAs in prostate cancer.
    Waltering KK; Porkka KP; Jalava SE; Urbanucci A; Kohonen PJ; Latonen LM; Kallioniemi OP; Jenster G; Visakorpi T
    Prostate; 2011 May; 71(6):604-14. PubMed ID: 20945501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constant Degradation of the Androgen Receptor by MDM2 Conserves Prostate Cancer Stem Cell Integrity.
    Vummidi Giridhar P; Williams K; VonHandorf AP; Deford PL; Kasper S
    Cancer Res; 2019 Mar; 79(6):1124-1137. PubMed ID: 30626627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
    Shiota M; Itsumi M; Takeuchi A; Imada K; Yokomizo A; Kuruma H; Inokuchi J; Tatsugami K; Uchiumi T; Oda Y; Naito S
    Endocr Relat Cancer; 2015 Dec; 22(6):889-900. PubMed ID: 26311513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Efflux Transporter ABCG2 Maintains Prostate Stem Cells.
    Sabnis NG; Miller A; Titus MA; Huss WJ
    Mol Cancer Res; 2017 Feb; 15(2):128-140. PubMed ID: 27856956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence.
    Ettinger SL; Sobel R; Whitmore TG; Akbari M; Bradley DR; Gleave ME; Nelson CC
    Cancer Res; 2004 Mar; 64(6):2212-21. PubMed ID: 15026365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1.
    Amler LC; Agus DB; LeDuc C; Sapinoso ML; Fox WD; Kern S; Lee D; Wang V; Leysens M; Higgins B; Martin J; Gerald W; Dracopoli N; Cordon-Cardo C; Scher HI; Hampton GM
    Cancer Res; 2000 Nov; 60(21):6134-41. PubMed ID: 11085537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.